Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FFKS7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,190
Award facts
- Contract value 100% obligated
- $2,189.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,189.92 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems on January 6, 2026, with final delivery required by January 28, 2026. This firm fixed-price delivery order was issued without a set-aside designation, allowing the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, to compete in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded November 13, 2025, that runs through December 31, 2036.
The PPV-G GEN V represents part of the broader $30.3 billion Defense Logistics Agency pharmaceutical acquisition strategy designed to supply the Department of Defense's global military healthcare operations with comprehensive pharmaceutical products and medical consumables. DMS Pharmaceutical Group's delivery order for Mirena contraceptive systems exemplifies the diverse product portfolio the company delivers under this prime vendor contract, which authorizes firm fixed-price orders for branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to support recurring medical supply needs across military healthcare facilities worldwide. No subcontractors are identified in the award documentation.
Quick answers
Who was awarded contract SPE2DR26FFKS7?
SPE2DR26FFKS7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FFKS7 worth?
The government has obligated $2,190 on SPE2DR26FFKS7.
Is contract SPE2DR26FFKS7 an order under another contract?
Yes. SPE2DR26FFKS7 is a delivery order under SPE2DR25D9212, an indefinite delivery contract.
Was contract SPE2DR26FFKS7 competed?
The extent of competition for SPE2DR26FFKS7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award